Wushu Chen1,2†
Ye Qiu- 1Gastroenterology and Respiratory Internal Medicine Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
- 2State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China
- 3Medical Oncology of Respiratory Medicine, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China
- 4Department of Respiratory and Critical Medicine, Yiyang Central Hospital, Yiyang, Hunan, China
A Corrigendum on
Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review
by Chen, W., Feng, X., Yao, L.-k., Li, X., Yang, Z.-m., Qin, X.-y., Li, Y., and Qiu, Y. (2025). Front. Med. 12:1552566. doi: 10.3389/fmed.2025.1552566
In the published article, the order of affiliations 1 and 2 was incorrect, “Gastroenterology and Respiratory Internal Medicine Department, Guangxi Medical University Cancer Hospital, Nanning, Guangxi, China” should be affiliation 1 and “State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China” should appear as affiliation 2.
In the published article, there was an error regarding the affiliation for Wushu Chen. As well as having affiliation 1, they should also have affiliation 2.
In the published article, the order of the corresponding authors in the correspondence section has been updated to:
Ye Qiu, eWVxaXUyMDEzZ3JhZHVhdGVkQDE2My5jb20=
Yu Li, bHkuMjAwNTIwMDhAMTYzLmNvbQ==
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: GM-CSF, aPAP, inhalation, subcutaneous injection, treatment dosage and duration
Citation: Chen W, Feng X, Yao L-k, Li X, Yang Z-m, Qin X-y, Li Y and Qiu Y (2025) Corrigendum: Exogenous GM-CSF therapy for autoimmune pulmonary alveolar proteinosis: a systematic literature review. Front. Med. 12:1632193. doi: 10.3389/fmed.2025.1632193
Received: 20 May 2025; Accepted: 22 May 2025;
Published: 03 June 2025.
Approved by:
Frontiers Editorial Office, Frontiers Media SA, SwitzerlandCopyright © 2025 Chen, Feng, Yao, Li, Yang, Qin, Li and Qiu. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Ye Qiu, eWVxaXUyMDEzZ3JhZHVhdGVkQDE2My5jb20=; Yu Li, bHkuMjAwNTIwMDhAMTYzLmNvbQ==
†These authors have contributed equally to this work and share first authorship